Skip to content
10-K

Annual Report

Eastgate Biotech Corp

0001640334-16-002061

← back to feed
Filed
Nov 18, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Oct 31, 2016 306.82M sh
Capex FY 2015 · Dec 31, 2014 $99.82K
Current Liabilities FY 2015 · Dec 31, 2014 $1.88M
Total Liabilities FY 2015 · Dec 31, 2014 $1.88M
Current Assets FY 2015 · Dec 31, 2014 $339.69K
Total Assets FY 2015 · Dec 31, 2014 $482.94K
Sga Expense FY 2015 · Dec 31, 2014 $3.72M
Rd Expense FY 2015 · Dec 31, 2014 $840.24K
Net Income FY 2015 · Dec 31, 2014 −$4.91M
Operating Income FY 2015 · Dec 31, 2014 −$4.82M
Cash And Equivalents FY 2015 · Dec 31, 2013 $458
Stockholders Equity FY 2015 · Dec 31, 2013 −$2.33M